Frequently Asked Questions Research References Therapeutic potential of pro-angiogenic BPC157 is associated with VEGFR2 activation and up-regulation (Hsieh et al., J Mol Med, 2017) BPC 157 promotes tendon healing via tendon outgrowth, cell survival and cell migration, FAK and paxillin phosphorylation (Chang et al., J Appl Physiol, 2011) Regeneration or Risk
Owing to their effectiveness in reducing body weight, once-daily subcutaneous administration of liraglutide 3.0 mg has been approved, and once-weekly subcutaneous administration of semaglutide 2.4 mg is being investigated in phase III trials, for obesity management
Perfect for dull or dry complexions, the APLB Glutathione Niacinamide Sheet Mask (Set of 10) delivers hydration and comfort while helping to improve overall skin tone
For type 2 diabetes, GLP-1 medications are typically long-term treatments due to the progressive nature of the condition, though some patients may reduce therapy with sustained lifestyle changes
Investigating GIPR (ant)agonism: a structural analysis of GIP and its receptor
Ferla, M